Eli Lilly and Company: Revision history

25 August 2023

• curprev 12:1712:17, 25 August 2023‎ 185.44.76.187 talk‎ 38,192 bytes +8,671‎ →‎Corporate Strategy undo Tag: Visual edit
• curprev 11:1611:16, 25 August 2023‎ 185.44.76.187 talk‎ 29,521 bytes +5,072‎ →‎Corporate Strategy undo Tag: Visual edit
• curprev 09:3709:37, 25 August 2023‎ 185.44.76.187 talk‎ 24,449 bytes +7,950‎ →‎Corporate Strategy undo Tag: Visual edit
• curprev 00:4900:49, 25 August 2023‎ Soranna talk contribs‎ 16,499 bytes +12‎ No edit summary undo Tag: Visual edit
• curprev 00:4800:48, 25 August 2023‎ Soranna talk contribs‎ 16,487 bytes +1,546‎ No edit summary undo Tag: Visual edit

21 August 2023

• curprev 16:1616:16, 21 August 2023‎ SaadYawar talk contribs‎ 14,941 bytes +11,557‎ PROJECTS undo Tag: Visual edit
• curprev 13:2813:28, 21 August 2023‎ SaadYawar talk contribs‎ 3,384 bytes +1,381‎ Overview & Background, Project summary undo Tag: Visual edit

19 August 2022

• curprev 22:3622:36, 19 August 2022‎ 95.149.241.133 talk‎ 2,003 bytes +11‎ No edit summary undo Tag: Visual edit: Switched

12 August 2022

• curprev 18:3318:33, 12 August 2022‎ 109.180.50.163 talk‎ 1,992 bytes +15‎ No edit summary undo Tag: Visual edit: Switched

31 July 2022

• curprev 22:3422:34, 31 July 2022‎ Chris talk contribs‎ 1,977 bytes +1,977‎ Created page with "Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant ple..." Tag: Visual edit